Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official. Federal government websites often end in . gov or . mil. Before sharing sensitive information, make sure you’re on a federal government site. VSports app下载.

Https

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. V体育官网.

. 2003 Oct;110(2):242-9.
doi: 10.1046/j.1365-2567.2003.01732.x.

Induction of a protective capsular polysaccharide antibody response to a multiepitope DNA vaccine encoding a peptide mimic of meningococcal serogroup C capsular polysaccharide

Affiliations

Induction of a protective capsular polysaccharide antibody response to a multiepitope DNA vaccine encoding a peptide mimic of meningococcal serogroup C capsular polysaccharide (VSports最新版本)

Deborah M Prinz et al. Immunology. 2003 Oct.

"VSports" Abstract

Systemic infection by encapsulated organisms, such as Neisseria meningitidis, is a major cause of morbidity and mortality worldwide, especially in individuals less than 2 years of age. Antibodies directed at the capsular polysaccharide are shown to be protective against disease by inducing complement-dependent bactericidal activity. The current polysaccharide vaccine has been shown to be poorly immunogenic in high-risk groups and this is probably related to its T-independent properties. An alternative approach to eliciting a T-dependent serum immunoglobulin G (IgG) antibody response to encapsulated pathogens is DNA vaccination. We assessed the immunogenicity of a multiepitope DNA vaccine encoding a T-cell helper epitope and a peptide mimic of N. meningitidis serogroup C. The DNA construct induced a significant anti-polysaccharide antibody response that was bactericidal VSports手机版. Mice immunized with the DNA construct were subsequently protected against challenge with a lethal dose of N. meningitidis serogroup C. .

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mice (n = 6) were immunized with 100 µg of DNA and 40 µg of aluminum phosphate gel adjuvant on days 0, 21, and 63. Positive controls were immunized with 5 µg of meningococcal serogroup C capsular polysaccharide (MCPS) on day 0. The anti-MCPS immunoglobulin response was determined by enzyme-linked immunosorbent assay (ELISA). The geometric mean immunoglobulin M (IgM) antibody titre of each group is represented by a column. *Statistical significance of groups compared with the negative control (P ≤ 0·05).
Figure 2
Figure 2
Functional activity in postimmune sera was determined by serum bactericidal assays on day 56. Geometric mean bactericidal titres for each group are indicated by columns; individual mouse titres are denoted by circles. Some circles may be representative of more than one mouse in a group. *Statistical significance of groups compared with the negative control (P ≤ 0·05).
Figure 3
Figure 3
Mice immunized with DNA and meningococcal serogroup C capsular polysaccharide (MCPS) were challenged with a lethal dose of Neisseria meningitidis serogroup C strain 35E. Ninety-six hours postchallenge, sera were collected from survivors and anti-MCPS IgG1, IgG2a, IgG2b, and IgG3 were determined by enzyme-linked immunosorbent assay (ELISA). Geometric mean pre- and postchallenge antibody titres for each isotype are represented by columns; individual mouse titres are denoted by circles. Some circles may be representative of more than one mouse. *Statistical significance of the test group compared with controls (P ≤ 0·05).
Figure 3
Figure 3
Mice immunized with DNA and meningococcal serogroup C capsular polysaccharide (MCPS) were challenged with a lethal dose of Neisseria meningitidis serogroup C strain 35E. Ninety-six hours postchallenge, sera were collected from survivors and anti-MCPS IgG1, IgG2a, IgG2b, and IgG3 were determined by enzyme-linked immunosorbent assay (ELISA). Geometric mean pre- and postchallenge antibody titres for each isotype are represented by columns; individual mouse titres are denoted by circles. Some circles may be representative of more than one mouse. *Statistical significance of the test group compared with controls (P ≤ 0·05).

References (V体育安卓版)

    1. van Deuren M, Brandtzaeg P, van der Meer JWM. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microb Rev. 2000;13:144–6. - PMC - PubMed
    1. Rosenstein NE, Perkins BA, Stephens DS, et al. The changing epidemiology of meningococcal disease in the United States, 1992–1996. J Infect Dis. 1999;180:1894–901. - PubMed
    1. Moore PS. Meningococcal meningitis in sub-saharan Africa: a model for the epidemic process. Clin Infect Dis. 1992;14:515–25. - PubMed
    1. Raymond NJ, Reeves M, Ajello G, et al. Molecular epidemiology of sporadic (endemic) serogroup C meningococcal disease. J Infect Dis. 1997;176:1277–84. - "VSports注册入口" PubMed
    1. Jackson LA, Schuchat A, Reeves MW, Wenger JD. Serogroup C meningococcal outbreaks in the United States. JAMA. 1995;273:383–9. - PubMed

"VSports" Publication types

VSports - MeSH terms

LinkOut - more resources